Randox Acetaminophen Reagent

sPLA₂-IIA otherwise known as Secretory Phospholipase A₂, is a novel cardiac biomarker which acts as a predictor of coronary risk and an aid in the prognosis of patients with Coronary Heart Disease (CHD) and cardiovascular events.

sPLA₂-IIA: Targeting primary and secondary risk

  • Coronary Heart Disease
  • Acute Coronary Syndrome
  • Associated risk conditions
Clinical Laboratory Survey